{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:41:51Z","timestamp":1787794911937,"version":"build-2784847793"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International Partnership for Microbicides"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>A 25-mg dapivirine vaginal ring has been demonstrated to reduce risk of human immunodeficiency virus (HIV) acquisition in nonpregnant adult women. In this secondary analysis of studies conducted in US adolescent, lactating, and postmenopausal females, vaginal microbiota was assessed prior to and after ring use, and between dapivirine and placebo ring users.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Vaginal fluid swabs were collected before and after product use for the evaluation of microbiota using Nugent criteria, quantitative culture, and quantitative polymerase chain reaction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Vaginal ring use did not impact bacterial vaginosis prevalence among the 3 populations and was associated with minimal shifts in microbiota. Adolescents in both arms demonstrated an increased prevalence of Lactobacillus crispatus and a decrease in quantity of Megasphaera lornae. Postmenopausal active and placebo ring users demonstrated an increased prevalence of lactobacilli and non-albicans yeast, while dapivirine ring users demonstrated an increased prevalence of Candida albicans and increased quantity of group B Streptococcus and non-albicans yeasts. Prevotella species were increased in lactating women, whereas Prevotella timonensis increased in prevalence and concentration among adolescent and postmenopausal females and Prevotella bivia increased in prevalence among adolescent dapivirine ring users.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Dapivirine vaginal ring use was associated with minimal changes in the vaginal microbiota that are likely not clinically significant.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiab590","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T12:11:26Z","timestamp":1638533486000},"page":"2208-2218","source":"Crossref","is-referenced-by-count":9,"title":["Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females"],"prefix":"10.1093","volume":"225","author":[{"given":"Michele N","family":"Austin","sequence":"first","affiliation":[{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A","family":"Meyn","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania , USA"},{"name":"University of Pittsburgh , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary A","family":"Avolia","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda A","family":"Petrina","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Cosentino","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calins","family":"Alphonse","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-4632","authenticated-orcid":false,"given":"Beatrice A","family":"Chen","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania , USA"},{"name":"University of Pittsburgh , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Bunge","sequence":"additional","affiliation":[{"name":"University of Pittsburgh , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Beigi","sequence":"additional","affiliation":[{"name":"University of Pittsburgh , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Squires","sequence":"additional","affiliation":[{"name":"Thomas Jefferson University , Philadelphia, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L","family":"Hillier","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania , USA"},{"name":"University of Pittsburgh , Pittsburgh, Pennsylvania , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,4]]},"reference":[{"key":"2022061517103367700_CIT0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13690-018-0299-8","article-title":"Gender disparity in epidemiological trend of HIV\/AIDS infection and treatment in Ethiopia.","volume":"76","author":"Girum","year":"2018","journal-title":"Arch Public Health"},{"key":"2022061517103367700_CIT0002","author":"American Foundation for AIDS Research."},{"key":"2022061517103367700_CIT0003","first-page":"193","article-title":"Beyond the pap smear: gender-responsive HIV care for women.","volume":"89","author":"Meyer","year":"2016","journal-title":"Yale J Biol Med"},{"key":"2022061517103367700_CIT0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4081\/idr.2011.e6","article-title":"Advances in the prevention of heterosexual transmission of HIV\/AIDS among women in the United States.","volume":"3","author":"Chen","year":"2011","journal-title":"Infect Dis Rep"},{"key":"2022061517103367700_CIT0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11908-018-0618-9","article-title":"Biomedical approaches to HIV prevention in women.","volume":"20","author":"Heumann","year":"2018","journal-title":"Curr Infect Dis Rep"},{"key":"2022061517103367700_CIT0006","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/IJWH.S34030","article-title":"Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.","volume":"5","author":"Thurman","year":"2013","journal-title":"Int J Womens Health"},{"key":"2022061517103367700_CIT0007","first-page":"63","article-title":"Biomedical prevention of HIV in women: challenges and approaches, with particular reference to the vaginal microbiome.","volume":"129","author":"Marrazzo","year":"2018","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2022061517103367700_CIT0008","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-med-090518-093731","article-title":"Topical microbicides in HIV prevention: state of the promise.","volume":"71","author":"Baeten","year":"2020","journal-title":"Annu Rev Med"},{"key":"2022061517103367700_CIT0009","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention.","volume":"375","author":"Baeten","year":"2016","journal-title":"N Engl J Med"},{"key":"2022061517103367700_CIT0010","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women.","volume":"375","author":"Nel","year":"2016","journal-title":"N Engl J Med"},{"key":"2022061517103367700_CIT0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajog.2018.10.014","article-title":"Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention.","volume":"220","author":"Bayigga","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2022061517103367700_CIT0012","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","article-title":"Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract.","volume":"42","author":"Anahtar","year":"2015","journal-title":"Immunity"},{"key":"2022061517103367700_CIT0013","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/QAD.0000000000001768","article-title":"Vaginal microbiota and susceptibility to HIV.","volume":"32","author":"Eastment","year":"2018","journal-title":"AIDS"},{"key":"2022061517103367700_CIT0014","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/COH.0000000000000431","article-title":"The microbiome and HIV prevention strategies in women.","volume":"13","author":"Abdool Karim","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"key":"2022061517103367700_CIT0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sextrans-2018-053949","article-title":"Associations between vaginal bacteria implicated in HIV acquisition risk and proinflammatory cytokines and chemokines.","volume":"96","author":"Sabo","year":"2019","journal-title":"Sex Transm Infect"},{"key":"2022061517103367700_CIT0016","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1473-3099(18)30058-6","article-title":"Key vaginal bacteria associated with increased risk of HIV acquisition in African women: a nested case-control study.","volume":"18","author":"McClelland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2022061517103367700_CIT0017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2016.12.013","article-title":"Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women.","volume":"46","author":"Gossman","year":"2017","journal-title":"Immunity"},{"key":"2022061517103367700_CIT0018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11904-018-0380-5","article-title":"The influence of cervicovaginal microbiota on mucosal immunity and prophylaxis in the battle against HIV.","volume":"15","author":"Farcasanu","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2022061517103367700_CIT0019","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/QAD.0000000000002751","article-title":"Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.","volume":"35","author":"Farr Zuend","year":"2021","journal-title":"AIDS"},{"key":"2022061517103367700_CIT0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/QAI.0000000000000702","article-title":"Phase 1 safety, pharmacokinetics and pharmacodynamics of dapivirine and maraviroc vaginal rings: a double-blind randomized trial.","volume":"70","author":"Chen","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022061517103367700_CIT0021","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/QAD.0000000000000280","article-title":"A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in health women.","volume":"28","author":"Nel","year":"2014","journal-title":"AIDS"},{"key":"2022061517103367700_CIT0022","first-page":"355","article-title":"Pharmacokinetics and safety assessment of anti-HIV dapivirine vaginal microbicide rings with multiple dosing.","volume":"5","author":"Nel","year":"2014","journal-title":"J AIDS Clin Res"},{"key":"2022061517103367700_CIT0023","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMc1616546","article-title":"Dapivirine vaginal ring for HIV-1 prevention.","volume":"376","author":"Baeten","year":"2017","journal-title":"N Engl J Med"},{"key":"2022061517103367700_CIT0024","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jcph.1270","article-title":"Pharmacology of antiretrovirals in the female genital tract for HIV prevention.","volume":"58","author":"Nicol","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"2022061517103367700_CIT0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0000000000002244","article-title":"Brief report: phase IIa safety study of a vaginal ring containing dapivirine in adolescent young women.","volume":"83","author":"Bunge","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022061517103367700_CIT0026","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/ciy654","article-title":"Phase 2a safety, pharmacokinetics, and acceptability of dapivirine vaginal rings in US postmenopausal women.","volume":"68","author":"Chen","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022061517103367700_CIT0027","doi-asserted-by":"crossref","first-page":"e01930","DOI":"10.1128\/AAC.01930-18","article-title":"Pharmacokinetics of dapivirine transfer into blood plasma, breast milk and cervicovaginal fluid of lactating women using the dapivirine vaginal ring.","volume":"63","author":"Noguchi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022061517103367700_CIT0028","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation.","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"key":"2022061517103367700_CIT0029","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007435-200205000-00007","article-title":"Microflora changes with the use of a vaginal microbicide.","volume":"29","author":"Clarke","year":"2002","journal-title":"Sex Trans Dis"},{"key":"2022061517103367700_CIT0030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2018.02.017","article-title":"Impact of contraceptive initiation on vaginal microbiota.","volume":"218","author":"Achilles","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2022061517103367700_CIT0031","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1099\/ijsem.0.004107","article-title":"A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae.","volume":"70","author":"Zheng","year":"2020","journal-title":"Int J Syst Evol Microbiol"},{"key":"2022061517103367700_CIT0032","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/JCM.00851-09","article-title":"Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis.","volume":"48","author":"Zozaya-Hinchcliffe","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2022061517103367700_CIT0033","doi-asserted-by":"crossref","first-page":"e00204","DOI":"10.1128\/mBio.00204-15","article-title":"Metabolic signatures of bacterial vaginosis.","volume":"6","author":"Srinivasan","year":"2015","journal-title":"mBio"},{"key":"2022061517103367700_CIT0034","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women.","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061517103367700_CIT0035","first-page":"826","article-title":"Lactobacillus iners, the usual suspect.","volume-title":"Res Microbiol","author":"Vaneechoutte","year":"2017"},{"key":"2022061517103367700_CIT0036","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nm.4506","article-title":"Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women.","volume":"24","author":"McKinnon","year":"2018","journal-title":"Nat Med"},{"key":"2022061517103367700_CIT0037","doi-asserted-by":"crossref","first-page":"103085","DOI":"10.1016\/j.jri.2020.103085","article-title":"Vaginal dysbiosis associated-bacteria Megasphaera elsdenii and Prevotella timonensis induce immune activation via dendritic cells.","volume":"138","author":"van Teijlingen","year":"2020","journal-title":"J Reprod Immunol"},{"key":"2022061517103367700_CIT0038","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.aai9383","article-title":"Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.","volume":"356","author":"Klatt","year":"2017","journal-title":"Science"},{"key":"2022061517103367700_CIT0039","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11904-017-0362-z","article-title":"The vaginal microbiome and its potential to impact efficacy of HIV pre-exposure prophylaxis for women.","volume":"14","author":"Vellozza","year":"2017","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2022061517103367700_CIT0040","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1093\/geronb\/gbu105","article-title":"Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States.","volume":"69","author":"Hoffman","year":"2014","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"2022061517103367700_CIT0041","doi-asserted-by":"crossref","first-page":"e0134460","DOI":"10.1371\/journal.pone.0134460","article-title":"Effects of a one-year reusable contraceptive vaginal ring on vaginal microflora and the risk of vaginal infection: an open-label prospective evaluation.","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"2022061517103367700_CIT0042","doi-asserted-by":"crossref","first-page":"e1009024","DOI":"10.1371\/journal.ppat.1009024","article-title":"Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism.","volume":"16","author":"Cheu","year":"2020","journal-title":"PLoS Pathog"},{"key":"2022061517103367700_CIT0043","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fmed.2018.00181","article-title":"The vaginal microenvironment: the physiologic role of lactobacilli.","volume":"5","author":"Amabebe","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"2022061517103367700_CIT0044","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2180-5-61","article-title":"Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora.","volume":"5","author":"Verhelst","year":"2005","journal-title":"BMC Microbiol"},{"key":"2022061517103367700_CIT0045","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajog.2019.10.032","article-title":"When normal isn\u2019t normal: heterogeneity in dominant Lactobacillus species among women having a Nugent score of 0\u20133.","volume":"221","author":"Meyn","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2022061517103367700_CIT0046","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/aid.2016.0320","article-title":"Comparison of mucosal markers of human immunodeficiency virus susceptibility in health premenopausal versus postmenopausal women.","volume":"33","author":"Thurman","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022061517103367700_CIT0047","doi-asserted-by":"crossref","first-page":"324.e1","DOI":"10.1016\/j.ajog.2016.03.041","article-title":"Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.","volume":"215","author":"Jais","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2022061517103367700_CIT0048","doi-asserted-by":"crossref","first-page":"e40415","DOI":"10.1371\/journal.pone.0040415","article-title":"Altered biomarkers of mucosal immunity and reduced vaginal Lactobacillus concentrations in sexually female adolescents.","volume":"7","author":"Madan","year":"2012","journal-title":"PLoS One"},{"key":"2022061517103367700_CIT0049","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiy113","article-title":"Increased risk of HIV acquisition among women throughout pregnancy and during the postpartum period: a prospective per-coital-act analysis among women with HIV-infected partners.","volume":"218","author":"Thompson","year":"2018","journal-title":"J Infect Dis"},{"key":"2022061517103367700_CIT0050","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1089\/aid.2016.0206","article-title":"Understanding the intersection of young age, mucosal injury and HIV susceptibility.","volume":"32","author":"Porter","year":"2016","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/12\/2208\/44082658\/jiab590.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab590\/41981987\/jiab590.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/12\/2208\/44082658\/jiab590.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T17:12:00Z","timestamp":1655313120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/225\/12\/2208\/6449486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,4]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,4]]},"published-print":{"date-parts":[[2022,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab590","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,15]]},"published":{"date-parts":[[2021,12,4]]}}}